BioMaxima S.A. Logo

BioMaxima S.A.

ISIN: PLBIOMX00015 | Ticker: BMX | LEI: 2594007GAALFMXP4YB89
Sector: Health CareSub-Industry: Health Care Equipment
Country: Poland

About BioMaxima S.A.

Company Description

BioMaxima S.A. is a Polish company listed on GPW Main Market, producer of microbiology media as well as a wide range of reagents and in vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical, Biologist. The company holds Certificates of the Quality Management System ISO 9001: 2015 and ISO 13485:2016. Company's products are CE marked and meet the requirements of the Parliament and of the Council (EU) 2017/746. Owing to a wide range of products, BioMaxima is a significant partner for many clients from the clinical, veterinary and industrial diagnostics market both in Poland (where we supply over 1800 laboratories) and in international markets, where we serve over 60 distributors on four continents.

Year founded

1997

Served area

Worldwide

Headquarters

Vetterów 5, 20-277 Lublin – Poland

Financial statements

Download as Excel
Line item in (pln) 02.01.2021 01.01.2022 01.01.2023
Assets N/A 61,929,000.00 74,421,000.00
Noncurrent Assets N/A 28,384,000.00 38,196,000.00
Property Plant And Equipment N/A 27,869,000.00 37,761,000.00
Goodwill N/A 0.00 0.00
Intangible Assets Other Than Goodwill N/A 501,000.00 435,000.00
Deferred Tax Assets N/A 0.00 0.00
Other Noncurrent Financial Assets N/A 14,000.00 0.00
Current Assets N/A 33,545,000.00 36,225,000.00
Inventories N/A 14,024,000.00 12,821,000.00
Trade And Other Current Receivables N/A 16,512,000.00 10,083,000.00
Current Tax Assets Current N/A 0.00 401,000.00
Other Current Financial Assets N/A 13,000.00 13,000.00
Cash and cash equivalents 4,386,000.00 2,996,000.00 12,907,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 33,545,000.00 36,225,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 0.00 0.00
Equity And Liabilities N/A 61,929,000.00 74,421,000.00
Equity 19,885,000.00 29,193,000.00 52,456,000.00
Issued Capital N/A 4,320,000.00 4,329,000.00
Retained Earnings N/A 12,239,000.00 34,176,000.00
Share Premium N/A 9,841,000.00 9,841,000.00
Treasury Shares N/A 0.00 5,000,000.00
Other Reserves N/A 2,793,000.00 9,110,000.00
Equity Attributable To Owners Of Parent N/A 29,193,000.00 52,456,000.00
Noncontrolling Interests N/A 0.00 0.00
Liabilities N/A 32,736,000.00 21,965,000.00
Noncurrent Liabilities N/A 15,388,000.00 10,988,000.00
Noncurrent Provisions N/A 62,000.00 93,000.00
Noncurrent Government Grants N/A 6,173,000.00 6,019,000.00
Deferred Tax Liabilities N/A 533,000.00 766,000.00
Other Noncurrent Financial Liabilities N/A 8,020,000.00 3,861,000.00
Other Noncurrent Nonfinancial Liabilities N/A 0.00 0.00
Current Liabilities N/A 17,348,000.00 10,977,000.00
Current Provisions N/A 792,000.00 1,393,000.00
Trade And Other Current Payables N/A 6,719,000.00 7,389,000.00
Current Government Grants N/A 478,000.00 477,000.00
Current Tax Liabilities Current N/A 708,000.00 0.00
Other Current Financial Liabilities N/A 8,142,000.00 1,305,000.00
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale N/A 17,348,000.00 10,977,000.00
Liabilities Included In Disposal Groups Classified As Held For Sale N/A 0.00 0.00
Line item in (pln) 01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 79,088,000.00 143,867,000.00
Other Income 1,997,000.00 1,647,000.00
Changes In Inventories Of Finished Goods And Work In Progress 2,192,000.00 318,000.00
Other Work Performed By Entity And Capitalised 637,000.00 1,677,000.00
Raw Materials And Consumables Used 37,890,000.00 77,710,000.00
Cost Of Merchandise Sold 9,498,000.00 11,511,000.00
Services Expense 4,716,000.00 5,030,000.00
Employee Benefits Expense 10,570,000.00 12,457,000.00
Depreciation And Amortisation Expense 1,654,000.00 2,020,000.00
Other Expense By Nature 1,152,000.00 1,775,000.00
Profit Loss From Operating Activities 13,653,000.00 34,854,000.00
Finance Income 100,000.00 1,465,000.00
Finance Costs 322,000.00 486,000.00
Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 656,000.00 -36,000.00
Profit Loss Before Tax 12,775,000.00 35,869,000.00
Income Tax Expense Continuing Operations 2,532,000.00 6,984,000.00
Profit Loss From Continuing Operations 10,243,000.00 28,885,000.00
Profit Loss From Discontinued Operations 0.00 0.00
Profit (loss) 10,243,000.00 28,885,000.00
Profit Loss Attributable To Owners Of Parent 10,243,000.00 28,885,000.00
Profit Loss Attributable To Noncontrolling Interests 0.00 0.00
Line item in (pln) 01.01.2022 02.01.2021 01.01.2023
Profit (loss) 10,243,000.00 N/A 28,885,000.00
Adjustments For Reconcile Profit Loss -11,157,000.00 N/A 8,288,000.00
Adjustments For Decrease Increase In Inventories -3,627,000.00 N/A 1,030,000.00
Adjustments For Depreciation And Amortisation Expense 1,654,000.00 N/A 2,020,000.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 0.00 N/A 0.00
Adjustments For Provisions 561,000.00 N/A 633,000.00
Adjustments For Unrealised Foreign Exchange Losses Gains 77,000.00 N/A -26,000.00
Adjustments For Sharebased Payments 0.00 N/A 0.00
Adjustments For Fair Value Gains Losses 0.00 N/A 0.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets -54,000.00 N/A -1,000.00
Adjustments For Reconcile Profit Loss -11,157,000.00 N/A 8,288,000.00
Cash Flows From Used In Operations 1,618,000.00 N/A 44,157,000.00
Income Taxes Paid Refund Classified As Operating Activities 1,750,000.00 N/A 7,092,000.00
Cash Flows From Used In Operating Activities -132,000.00 N/A 37,065,000.00
Proceeds From Government Grants Classified As Investing Activities 834,000.00 N/A 1,226,000.00
Cash Advances And Loans Made To Other Parties Classified As Investing Activities 0.00 N/A 0.00
Cash Receipts From Repayment Of Advances And Loans Made To Other Parties Classified As Investing Activities 13,000.00 N/A 10,000.00
Dividends Received Classified As Investing Activities 0.00 N/A 0.00
Interest Received Classified As Investing Activities 0.00 N/A 811,000.00
Cash Flows From Used In Investing Activities -3,368,000.00 N/A -7,831,000.00
Payments From Changes In Ownership Interests In Subsidiaries 0.00 N/A 0.00
Proceeds From Issuing Shares 0.00 N/A 9,000.00
Payments To Acquire Or Redeem Entitys Shares 0.00 N/A 5,000,000.00
Proceeds From Borrowings Classified As Financing Activities 7,525,000.00 N/A 5,000.00
Repayments Of Borrowings Classified As Financing Activities 2,591,000.00 N/A 10,820,000.00
Payments Of Lease Liabilities Classified As Financing Activities 1,558,000.00 N/A 1,102,000.00
Dividends Paid Classified As Financing Activities 1,097,000.00 N/A 1,948,000.00
Interest Paid Classified As Financing Activities 169,000.00 N/A 467,000.00
Cash Flows From Used In Financing Activities 2,110,000.00 N/A -19,323,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes -1,390,000.00 N/A 9,911,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents 0.00 N/A 0.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes -1,390,000.00 N/A 9,911,000.00
Cash and cash equivalents 2,996,000.00 4,386,000.00 12,907,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
POL
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
POL
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

PLBIOMX00015

LEI

2594007GAALFMXP4YB89

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Warsaw Stock Exchange

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.